Tag: Claudin
Antengene Announces Claudin 18.2 Antibody-Drug Conjugate ATG-022 Granted Orphan … –...
SHANGHAI and HONG KONG, May 23, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated...